Erja-Leena Paukkeri

Aktiviteetit

Aktiviteetteja vuodessa 2006 2008 2011 2012 2013 2014

• 30 Konferenssiesitelmä

Aktiviteetteja vuodessa

Hakutulokset

• PPARalpha agonist fenofibrate and PPARγ agonist GW1929 differently regulate classical and alternative activation pathways in macrophages

  Paukkeri, E.-L. (Contributor), Moilanen, E. (Contributor) & Pemmari, A. (Contributor)

  11 helmik. 2014

  Aktiviteetti: Konferenssiesitelmä

• PPARalpha agonist fenofibrate and PPARγ agonist GW1929 differently regulate classical and alternative activation pathways in macrophages

  Paukkeri, E.-L. (Speaker), Moilanen, E. (Speaker) & Pemmari, A. (Speaker)

  23 tammik. 2014

  Aktiviteetti: Konferenssiesitelmä

• Effects of biodegradable polylactic acid fibers and dexamethasone on classical and alternative activation pathways in macrophages

  Hämäläinen, M. (Contributor), Moilanen, E. (Contributor), Nieminen, R. (Contributor), Paukkeri, E.-L. (Contributor), Pemmari, A. (Contributor) & Tammela, T. (Contributor)

  23 elok. 2013

  Aktiviteetti: Konferenssiesitelmä

• Inflammatory phenotype in peri-implant tissue associates with blood metal concentrations in patents with failed metal-on-metal hip prostheses

  Paukkeri, E.-L. (Contributor), Korhonen, R. (Contributor), Eskelinen, A. (Contributor), Pesu, M. (Contributor), Moilanen, E. (Contributor) & Moilanen, T. (Contributor)

  20 huhtik. 2013

  Aktiviteetti: Konferenssiesitelmä

• PPARalpha agonist fenofibrate and PPARgamma agonist GW1929 differently regulate classical and alternative activation pathways in macrophages

  Pemmari, A. (Contributor), Moilanen, E. (Contributor) & Paukkeri, E.-L. (Contributor)

  21 maalisk. 2013

  Aktiviteetti: Konferenssiesitelmä

• Effects of biodegradable polylactic acid fibres and dexamethasone on classical and alternative activation pathways in macraphages

  Räihä, M. (Contributor), Paukkeri, E.-L. (Contributor), Nieminen, R. (Contributor), Pemmari, A. (Contributor), Kellomäki, M. (Contributor), Tammela, T. (Contributor), Talja, M. (Contributor) & Moilanen, E. (Contributor)

  21 maalisk. 2013

  Aktiviteetti: Konferenssiesitelmä

• PPARalpha agonist fenofibrate and PPARgamma agonist GW1929 differently regulate classical and alternative activation pathways in macrophages

  Pemmari, A. (Contributor), Paukkeri, E.-L. (Contributor) & Moilanen, E. (Contributor)

  14 maalisk. 2013

  Aktiviteetti: Konferenssiesitelmä

• Metal concentrations in patients with failed metal-on-metal hip prostheses determine the inflammatory phenotype in peri-implant tissue

  Paukkeri, E.-L. (Contributor), Korhonen, R. (Contributor), Eskelinen, A. (Contributor), Pesu, M. (Contributor), Moilanen, T. (Contributor) & Moilanen, E. (Contributor)

  14 maalisk. 2013

  Aktiviteetti: Konferenssiesitelmä

• Metal concentrations in patients with failed metal-on-metal hip prostheses determine the inflammatory phenotype in peri-implant tissue

  Paukkeri, E.-L. (Speaker), Korhonen, R. (Speaker), Eskelinen, A. (Speaker), Pesu, M. (Speaker), Moilanen, T. (Speaker) & Moilanen, E. (Speaker)

  14 helmik. 2013

  Aktiviteetti: Konferenssiesitelmä

• PPAR gamma and PPAR delta agonists downregulate interleukin-1-stimulated inflammatory responses in human chondrocytes

  Paukkeri, E.-L. (Speaker), Hämäläinen, M. (Speaker), Moilanen, T. (Speaker) & Moilanen, E. (Speaker)

  24 tammik. 2013

  Aktiviteetti: Konferenssiesitelmä

• Metal concentrations in patients with failed metal-on-metal hip prostheses determine the inflammatory phenotype in peri-omplant tissue

  Paukkeri, E.-L. (Contributor), Eskelinen, A. (Contributor), Korhonen, R. (Contributor), Moilanen, E. (Contributor), Moilanen, T. (Contributor), Pesu, M. (Contributor) & Vasama, K. (Contributor)

  12 marrask. 2012

  Aktiviteetti: Konferenssiesitelmä

• PPARgamma and PPARdelta agonists downregulate interleukin-1-stimulated inflammatory responses in human chondrocytes

  Paukkeri, E.-L. (Speaker), Hämäläinen, M. (Speaker), Moilanen, T. (Speaker) & Moilanen, E. (Speaker)

  16 elok. 2012

  Aktiviteetti: Konferenssiesitelmä

• Effects of biodegradable polylactic acid fibers and dexamethasone on classically and alternatively activated macrophages

  Hämäläinen, M. (Contributor), Moilanen, E. (Contributor), Nieminen, R. (Contributor), Paukkeri, E.-L. (Contributor) & Pemmari, A. (Contributor)

  20 heinäk. 2012

  Aktiviteetti: Konferenssiesitelmä

• PPARalpha agonist fenofibrate and PPARgamma agonist GW1929 differently regulate classical and alternative activation pathways in macrophages

  Pemmari, A. (Speaker), Moilanen, E. (Speaker) & Paukkeri, E.-L. (Speaker)

  20 heinäk. 2012

  Aktiviteetti: Konferenssiesitelmä

• PPARgamma and PPARdelta agonists downregulate interleukin-1-stimulated inflammatory responses in human chondrocytes

  Paukkeri, E.-L. (Contributor), Hämäläinen, M. (Contributor), Moilanen, T. (Contributor) & Moilanen, E. (Contributor)

  11 heinäk. 2012

  Aktiviteetti: Konferenssiesitelmä

• Metal concentrations in patients with failed metal-on-metal hip prostheses are connected to inflammatory phenotype in peri-implant tissue

  Paukkeri, E.-L. (Contributor), Korhonen, R. (Contributor), Eskelinen, A. (Contributor), Pesu, M. (Contributor), Vasama, K. (Contributor), Moilanen, T. (Contributor) & Moilanen, E. (Contributor)

  21 maalisk. 2012

  Aktiviteetti: Konferenssiesitelmä

• Anti-inflammatory properties of a dual PPARgamma/alpha agonist muraglitazar in in vitro and in vivo models

  Paukkeri, E.-L. (Contributor), Leppänen, T. (Contributor) & Moilanen, E. (Contributor)

  15 elok. 2011

  Aktiviteetti: Konferenssiesitelmä

• Anti-inflammatory properties of a dual PPARγ/α agonist muraglitazar in in vitro and in vivo models

  Paukkeri, E.-L. (Contributor), Lindholm, M. (Contributor), Leppänen, T. (Contributor), Aulaskari, P. (Contributor), Yam, M. (Contributor), Asmawi, M. (Contributor) & Moilanen, E. (Contributor)

  25 maalisk. 2011

  Aktiviteetti: Konferenssiesitelmä

• Anti-inflammatory properties of a dual PPARγ/α agonist muraglitazar in in vitro and in vivo models

  Paukkeri, E.-L. (Contributor), Leppänen, T. (Contributor) & Moilanen, E. (Contributor)

  10 helmik. 2011

  Aktiviteetti: Konferenssiesitelmä

• Anti-inflammatory properties of a dual PPARgamma/alpha agonist muraglitazar in in vitro and in vivo models

  Paukkeri, E.-L. (Speaker), Leppänen, T. (Speaker) & Moilanen, E. (Speaker)

  28 tammik. 2011

  Aktiviteetti: Konferenssiesitelmä

• Anti-inflammatory properties of a dual PPARgamma/alpha agonist muraglitazar in in vitro and in vivo models

  Paukkeri, E.-L. (Contributor), Leppänen, T. (Contributor) & Moilanen, E. (Contributor)

  30 elok. 2010

  Aktiviteetti: Konferenssiesitelmä

• Anti-inflammatory properties of a dual PPARgamma/alpha agonist muraglitazar in in vitro and in vivo models

  Paukkeri, E.-L. (Contributor), Lindholm, M. (Contributor), Leppänen, T. (Contributor), Aulaskari, P. (Contributor), Yam, M. (Contributor), Asmawi, M. (Contributor) & Moilanen, E. (Contributor)

  17 heinäk. 2010

  Aktiviteetti: Konferenssiesitelmä

• PPARalpha agonists inhibit nitric oxide production by enhancing iNOS degradation in activated macrophages

  Paukkeri, E.-L. (Speaker), Kankaanranta, H. (Speaker), Leppänen, T. (Speaker) & Moilanen, E. (Speaker)

  23 tammik. 2009

  Aktiviteetti: Konferenssiesitelmä

• CAMP-enhancing compounds regulate tristetraprolin expression. Distinct effects in resting cells and in cells exposed to inflammatory stimuli

  Jalonen, U. (Contributor), Kankaanranta, H. (Contributor), Leppänen, T. (Contributor), Moilanen, E. (Contributor) & Paukkeri, E.-L. (Contributor)

  12 lokak. 2008

  Aktiviteetti: Konferenssiesitelmä

• CAMP-enhancing compounds regulate tristetraprolin expression. Distinct effects in resting cells and in cells exposed to inflammatory stimuli

  Jalonen, U. (Contributor), Kankaanranta, H. (Contributor), Leppänen, T. (Contributor), Moilanen, E. (Contributor) & Paukkeri, E.-L. (Contributor)

  24 kesäk. 2008

  Aktiviteetti: Konferenssiesitelmä

• E cAMP-enhancing compounds regulate tristetraprolin expression. Distinct effects in resting cells and in cells exposed to inflammatory stimuli

  Jalonen, U. (Contributor), Kankaanranta, H. (Contributor), Leppänen, T. (Contributor), Moilanen, E. (Contributor) & Paukkeri, E.-L. (Contributor)

  14 toukok. 2008

  Aktiviteetti: Konferenssiesitelmä

• Distinct actions of camp-enhancing compounds on tristetraprolin expression in murine J774 macrophages

  Jalonen, U. (Contributor), Leppänen, T. (Contributor), Paukkeri, E.-L. (Contributor), Kankaanranta, H. (Contributor) & Moilanen, E. (Contributor)

  13 maalisk. 2008

  Aktiviteetti: Konferenssiesitelmä

• PPARalpha agonists inhibit NO production by enhancing iNOS degradation in activated macrophages

  Paukkeri, E.-L. (Contributor), Kankaanranta, H. (Contributor), Leppänen, T. (Contributor) & Moilanen, E. (Contributor)

  22 maalisk. 2007

  Aktiviteetti: Konferenssiesitelmä

• PPAR agonists inhibit NO production by enhancing iNOS degradation in activated macrophages

  Paukkeri, E.-L. (Contributor), Kankaanranta, H. (Contributor), Leppänen, T. (Contributor) & Moilanen, E. (Contributor)

  19 lokak. 2006

  Aktiviteetti: Konferenssiesitelmä

• PPAR agonists inhibit NO production by enhancing iNOS degradation in activated macrophages

  Paukkeri, E.-L. (Contributor), Leppänen, T. (Contributor), Kankaanranta, H. (Contributor) & Moilanen, E. (Contributor)

  2 heinäk. 2006

  Aktiviteetti: Konferenssiesitelmä